-
EP3302533
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP3302533
| EP3302533 - COMPOSITIONS COMPRISING ADAMTS13 FOR USE IN METHODS FOR THE RECANALIZATION OF OCCLUDED BLOOD VESSELS IN AN INFARCTION [Right-click to bookmark this link] | Status | The application has been withdrawn Status updated on 03.12.2021 Database last updated on 01.01.2025 | |
| Former | Examination is in progress Status updated on 26.07.2019 | ||
| Former | Request for examination was made Status updated on 09.03.2018 | ||
| Former | The international publication has been made Status updated on 02.12.2016 | Most recent event Tooltip | 03.12.2021 | Withdrawal of application | published on 05.01.2022 [2022/01] | Applicant(s) | For all designated states Baxalta Incorporated 1200 Lakeside Drive Bannockburn, IL 60015 / US | For all designated states Baxalta GmbH Thurgauerstrasse 130 8152 Glattpark (Opfikon) / CH | For all designated states Katholieke Universiteit Leuven K.U. Leuven R&D Waaistraat 6 Box 5105 3000 Leuven / BE | [2020/17] |
| Former [2018/15] | For all designated states Baxalta Incorporated 1200 Lakeside Drive Bannockburn, IL 60015 / US | ||
| For all designated states Baxalta GmbH Thurgauerstrasse 130 8152 Glattpark, Opfikon / CH | |||
| For all designated states Katholieke Universiteit Leuven K.U. Leuven R&D Waaistraat 6 Box 5105 3000 Leuven / BE | Inventor(s) | 01 /
PLAIMAUER, Barbara Boecklinstrasse 102/10 1020 Vienna / AT | 02 /
ROTTENSTEINER, Hanspeter Haidgasse 10/17 1020 Vienna / AT | 03 /
SCHEIFLINGER, Friedrich Michelbeuerngasse 4/17 1090 Wien / AT | 04 /
DE MEYER, Simon Roeselarestraat 61 8830 Hooglede / BE | 05 /
DENORME, Frederik Deerkijksestraat 2 Bus 12 8500 Kortrijk / BE | [2018/15] | Representative(s) | Hoffmann Eitle Patent- und Rechtsanwälte PartmbB Arabellastraße 30 81925 München / DE | [2018/15] | Application number, filing date | 16729425.5 | 26.05.2016 | [2018/15] | WO2016US34353 | Priority number, date | US201562166586P | 26.05.2015 Original published format: US 201562166586 P | [2018/15] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2016191565 | Date: | 01.12.2016 | Language: | EN | [2016/48] | Type: | A1 Application with search report | No.: | EP3302533 | Date: | 11.04.2018 | Language: | EN | The application published by WIPO in one of the EPO official languages on 01.12.2016 takes the place of the publication of the European patent application. | [2018/15] | Search report(s) | International search report - published on: | EP | 01.12.2016 | Classification | IPC: | A61K38/48, A61P9/10 | [2018/15] | CPC: |
A61K38/4886 (EP,KR,US);
A61P9/00 (KR);
A61P9/10 (EP,US);
C12Y304/24087 (EP,US)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2018/15] | Title | German: | ZUSAMMENSETZUNGEN MIT ADAMTS13 ZUR VERWENDUNG BEI VERFAHREN ZUR REKANALISATION VON VERSTOPFTEN BLUTGEFÄSSEN BEI EINEM INFARKT | [2018/15] | English: | COMPOSITIONS COMPRISING ADAMTS13 FOR USE IN METHODS FOR THE RECANALIZATION OF OCCLUDED BLOOD VESSELS IN AN INFARCTION | [2018/15] | French: | COMPOSITIONS COMPRENANT ADAMTS13 POUR UTILISATION DANS DES PROCÉDÉS POUR LA RECANALISATION DE VAISSEAUX SANGUINS OCCLUS DANS UN INFARCTUS | [2018/15] | Entry into regional phase | 15.11.2017 | National basic fee paid | 15.11.2017 | Designation fee(s) paid | 15.11.2017 | Examination fee paid | Examination procedure | 15.11.2017 | Amendment by applicant (claims and/or description) | 15.11.2017 | Examination requested [2018/15] | 15.11.2017 | Date on which the examining division has become responsible | 30.07.2019 | Despatch of a communication from the examining division (Time limit: M06) | 03.03.2020 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time | 13.05.2020 | Reply to a communication from the examining division | 26.11.2021 | Application withdrawn by applicant [2022/01] | 26.11.2021 | Cancellation of oral proceeding that was planned for 06.12.2021 | 06.12.2021 | Date of oral proceedings (cancelled) | Divisional application(s) | EP21209904.8 | Request for further processing for: | The application is deemed to be withdrawn due to failure to reply to the examination report | 13.05.2020 | Request for further processing filed | 13.05.2020 | Full payment received (date of receipt of payment) Request granted | 26.05.2020 | Decision despatched | Fees paid | Renewal fee | 25.05.2018 | Renewal fee patent year 03 | 21.05.2019 | Renewal fee patent year 04 | 20.05.2020 | Renewal fee patent year 05 | 19.05.2021 | Renewal fee patent year 06 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [XYI]WO2009140140 (IMMUNE DISEASE INST [US], et al) [X] 1-19 * abstract * * page 1, paragraph 0001 - page 4, paragraph 0014 * * figures 1-9 * * page 14, paragraph 0053 - page 20, paragraph 0072 * * page 23, paragraph 0087 - page 31, paragraph 0118 * * claims 1-18 * [Y] 1-19 [I] 1-19; | [XYI]EP2172544 (CHEMO SERO THERAPEUT RES INST [JP]) [X] 1-19 * abstract * * paragraph [0002] - paragraph [0006] * * paragraph [0013] * * paragraph [0028] * * claims 1-14 * [Y] 1-19 [I] 1-19; | [XYI]WO2011035335 (BAXTER INT [US], et al) [X] 1-19 * abstract * * paragraphs [0022] , [0074] , [0230] - [0232] - [0262] - [0284] * * claim - * [Y] 1-19 [I] 1-19; | [XYI]CN103566362 (UNIV FUDAN) [X] 1-19 * abstract * * claim - * * page 1, paragraph 0001 - page 11, paragraph 0148 * [Y] 1-19 [I] 1-19; | [XYI]US2014271611 (SCHIVIZ ALEXANDRA NATHALIE [AT], et al) [X] 1-19 * abstract * * paragraphs [0002] - [0105] * * paragraphs [0106] - [0177] * * example - * * claim - * [Y] 1-19 [I] 1-19; | [XPYI] - NAKANO TAKAFUMI ET AL, "Delayed treatment with ADAMTS13 ameliorates cerebral ischemic injury without hemorrhagic complication", BRAIN RESEARCH, (20150805), vol. 1624, doi:10.1016/J.BRAINRES.2015.07.027, ISSN 0006-8993, pages 330 - 335, XP029290529 [XP] 1-19 * abstract * * page 331 - page 334 * [Y] 1-19 [I] 1-19 DOI: http://dx.doi.org/10.1016/j.brainres.2015.07.027 | [XYI] - M. M. KHAN ET AL, "ADAMTS13 reduces VWF-mediated acute inflammation following focal cerebral ischemia in mice", JOURNAL OF THROMBOSIS AND HAEMOSTASIS, GB, (20120801), vol. 10, no. 8, doi:10.1111/j.1538-7836.2012.04822.x, ISSN 1538-7933, pages 1665 - 1671, XP055293368 [X] 1-19 * abstract * * page 1665, column l, paragraph 1 - page 1670, column l, paragraph 1 * [Y] 1-19 [I] 1-19 DOI: http://dx.doi.org/10.1111/j.1538-7836.2012.04822.x | [XYI] - B.-Q. ZHAO ET AL, "von Willebrand factor-cleaving protease ADAMTS13 reduces ischemic brain injury in experimental stroke", BLOOD, US, (20091008), vol. 114, no. 15, doi:10.1182/blood-2009-03-213264, ISSN 0006-4971, pages 3329 - 3334, XP055293369 [X] 1-19 * abstract * * page 3329, column l, paragraph 1 - page 3333, column r, paragraph 2 * [Y] 1-19 [I] 1-19 DOI: http://dx.doi.org/10.1182/blood-2009-03-213264 | [XYI] - MASAYUKI FUJIOKA ET AL, "ADAMTS13 Protects the Brain against Ischemic Injury", JSM NEUROSURG SPINE, (20140101), vol. 2, no. 4, page 1-3, XP055293378 [X] 1-19 * pages 1-3 * [Y] 1-19 [I] 1-19 | [XYI] - M. D. I. VERGOUWEN ET AL, "Effect of recombinant ADAMTS-13 on microthrombosis and brain injury after experimental subarachnoid hemorrhage", JOURNAL OF THROMBOSIS AND HAEMOSTASIS, GB, (20140601), vol. 12, no. 6, doi:10.1111/jth.12574, ISSN 1538-7933, pages 943 - 947, XP055293540 [X] 1-19 * abstract * * pages 943-946 * [Y] 1-19 [I] 1-19 DOI: http://dx.doi.org/10.1111/jth.12574 |